Is BiomX Inc. (PHGE) a Buy, Sell, or Hold?
AMEX : PHGE
BiomX Inc. — Institutional Ownership
$0.1534 USD
-$0.01 (-3.4%)
- Volume
- 133.64K
- Average Volume
- 7.68M
- Market Capitalization
- $1.56M
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $12.29
- Year Low
- $0.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.24
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-16 | Deerfield Private Design Fund V, L.P. | 266.42K | 2.37% |
| 2026-06-16 | James E. Flynn | 533.37K | 4.70% |
| 2026-06-16 | Deerfield Management Company, L.P. | 533.37K | 4.70% |
| 2026-06-16 | Deerfield Mgmt HIF II, L.P. | 266.42K | 2.37% |
| 2026-06-16 | Deerfield Healthcare Innovations Fund II, L.P. | 266.42K | 2.37% |
| 2026-06-16 | Deerfield Mgmt V, L.P. | 266.42K | 2.37% |
| 2026-05-28 | James E. Flynn | 889.93K | 8.09% |
| 2026-05-28 | Deerfield Private Design Fund V, L.P. | 444.7K | 4.08% |
| 2026-05-28 | Deerfield Mgmt V, L.P. | 444.7K | 4.08% |
| 2026-05-28 | Deerfield Healthcare Innovations Fund II, L.P. | 444.7K | 4.08% |
| 2026-05-28 | Deerfield Mgmt HIF II, L.P. | 444.7K | 4.08% |
| 2026-05-28 | Deerfield Management Company, L.P. | 889.93K | 8.09% |
| 2026-05-14 | Rodney Hodges | 82618.0 | 5.20% |
| 2026-04-15 | Deerfield Mgmt V, L.P. | 494.27K | 5.64% |
| 2026-04-15 | Deerfield Private Design Fund V, L.P. | 494.27K | 5.64% |
| 2026-04-15 | Deerfield Mgmt HIF II, L.P. | 494.27K | 5.64% |
| 2026-04-15 | Deerfield Management Company, L.P. | 989.06K | 9.99% |
| 2026-04-15 | James E. Flynn | 989.06K | 9.99% |
| 2026-04-15 | Deerfield Healthcare Innovations Fund II, L.P. | 494.27K | 5.64% |
| 2026-04-14 | Water IO Ltd. | 1.3M | 16.57% |
| 2026-04-14 | Menachem Shalom | 1.6M | 20.40% |
| 2026-04-14 | T3 Defense Inc. | 1.3M | 16.57% |
| 2026-04-14 | Star 26 Capital Inc. | 1.3M | 16.57% |
| 2026-04-10 | Menachem Shalom | 1.3M | 19.87% |
| 2026-04-10 | Water IO Ltd. | 1.3M | 19.87% |
| 2026-04-10 | Star 26 Capital Inc. | 1.3M | 19.87% |
| 2026-04-10 | T3 Defense Inc. | 1.3M | 19.87% |
| 2026-02-17 | Alyeska Investment Group, L.P. | 38176.0 | 2.50% |
| 2026-02-13 | Nantahala Capital Management, LLC | 156.7K | 9.99% |
| 2026-02-11 | Deerfield Mgmt HIF II, L.P. | 494.27K | 9.99% |
| 2026-02-11 | Deerfield Healthcare Innovations Fund II, L.P. | 494.27K | 9.99% |
| 2026-02-11 | Deerfield Mgmt V, L.P. | 494.27K | 9.99% |
| 2026-02-11 | Deerfield Private Design Fund V, L.P. | 494.27K | 9.99% |
| 2026-02-11 | James E. Flynn | 989.06K | 9.99% |
| 2026-02-11 | Deerfield Management Company, L.P. | 989.06K | 9.99% |
| 2026-01-29 | Orin Hirschman | 38175.0 | 0.10% |
| 2026-01-26 | Reuven Yeganeh | 381.42K | 19.99% |
| 2026-01-26 | Pyu Pyu Capital, LLC | 381.42K | 19.99% |
| 2025-08-07 | Morgan Stanley | - | 0.00% |
| 2025-08-05 | Morgan Stanley | 1.85M | 7.10% |
| 2025-06-23 | GORDON CARL L | 276.15K | 1.00% |
| 2025-06-23 | CHIMOVITS EREZ | 276.15K | 1.00% |
| 2025-06-23 | ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | 276.15K | 1.00% |
| 2025-06-23 | ORBIMED ISRAEL GP LTD. | 276.15K | 1.00% |
| 2025-05-15 | Alyeska Investment Group, L.P. | 2.32M | 9.27% |
| 2025-05-15 | Rodney Hodges | 1.97M | 7.60% |
| 2025-05-15 | Nantahala Capital Management, LLC | 2.49M | 9.99% |
| 2025-05-08 | Orin Hirschman | 1.57M | 6.30% |
| 2025-03-04 | Cystic Fibrosis Foundation | 2.49M | 9.99% |
| 2025-03-03 | Deerfield Healthcare Innovations Fund II, L.P. | 7.78M | 9.99% |
| 2025-03-03 | Deerfield Mgmt HIF II, L.P. | 7.78M | 9.99% |
| 2025-03-03 | James E. Flynn | 15.56M | 9.99% |
| 2025-03-03 | Deerfield Private Design Fund V, L.P. | 7.78M | 9.99% |
| 2025-03-03 | Deerfield Management Company, L.P. | 15.56M | 9.99% |
| 2025-03-03 | Deerfield Mgmt V, L.P. | 7.78M | 9.99% |
| 2025-02-14 | Cystic Fibrosis Foundation | 4.09M | 19.99% |
| 2024-03-25 | AMR Action Fund, SCSp | 3.05M | 5.50% |
| 2024-03-25 | AMR Action Fund GP, LLC | 3.05M | 5.50% |
| 2024-03-25 | AMR Action Fund, L.P. | 3.05M | 5.50% |
| 2024-03-25 | AMR Action Fund, S.a r.l. | 3.05M | 5.50% |
| 2024-03-22 | Deerfield Healthcare Innovations Fund II, L.P. | 3.06M | 5.53% |
| 2024-03-22 | Deerfield Mgmt V, L.P. | 3.06M | 5.53% |
| 2024-03-22 | Deerfield Private Design Fund V, L.P. | 3.06M | 5.53% |
| 2024-03-22 | James E. Flynn | 6.11M | 11.06% |
| 2024-03-22 | Deerfield Mgmt HIF II, L.P. | 3.06M | 5.53% |
| 2024-03-22 | Deerfield Management Company, L.P. | 6.11M | 11.06% |
| 2023-09-29 | Centaurus Investments Limited | 2.84M | 6.20% |
| 2023-09-29 | Telmina Limited | 2.84M | 6.20% |
| 2023-09-29 | Geneva Holding Company (GHC) SA | 2.84M | 6.20% |
| 2023-09-29 | Geneva Trust Company (GTC) SA | 2.84M | 6.20% |
| 2023-09-29 | àrl | 2.84M | 6.20% |
| 2023-09-29 | Rodney Hodges | 2.84M | 6.20% |
| 2023-06-23 | Nimble Ventures, LLC | 4.6M | 9.99% |
| 2023-06-23 | John H. Burbank III | 4.6M | 9.99% |
| 2023-03-08 | Cystic Fibrosis Foundation | 2.75M | 8.10% |
| 2022-11-14 | Chidozie Ugwumba | 3M | 9.99% |
| 2022-08-05 | Takeda Pharmaceutical Company Limited | 1.48M | 4.96% |
| 2022-08-05 | Takeda Ventures, Inc. | 1.48M | 4.96% |
| 2022-02-14 | Thomas Layton Walton | - | 0.00% |
| 2022-02-14 | Chidozie Ugwumba | 5.51M | 19.28% |
| 2022-02-04 | MM Asset Management Inc. | 2.12M | 7.50% |
| 2022-02-04 | MMCAP International Inc. SPC | 2.12M | 7.50% |
| 2021-08-09 | Thomas Layton Walton | 5.51M | 17.80% |
| 2021-02-12 | MM Asset Management Inc. | 1.4M | 5.86% |
| 2021-02-12 | MMCAP International Inc. SPC | 1.4M | 5.86% |
| 2020-02-26 | S | 900K | 4.08% |
| 2020-02-26 | S | 900K | 4.08% |
| 2020-02-26 | S | 750.3K | 3.40% |
| 2020-02-14 | S | 900K | 3.94% |
| 2020-02-14 | S | 900K | 3.94% |
| 2020-02-14 | S | 750.3K | 3.29% |
| 2019-12-31 | Propper | 2.9M | 11.60% |
| 2019-12-31 | Mountain Wood, LLC | 2.9M | 11.60% |
| 2019-11-26 | EIN: 22-2007137 | 2.13M | 9.30% |
| 2019-11-26 | 22-1024240 | 2.13M | 9.30% |
| 2019-11-07 | OrbiMed Israel GP Ltd. | 2.29M | 10.00% |
| 2019-11-07 | OrbiMed Israel BioFund GP Limited Partnership | 2.29M | 10.00% |
| 2019-11-06 | Takeda Pharmaceutical Company Limited | 2.47M | 10.82% |
| 2019-11-06 | Takeda Ventures, Inc. | 2.47M | 10.82% |
| 2019-09-19 | MM Asset Management Inc. | 1.7M | 18.86% |
| 2019-09-19 | MMCAP International Inc. SPC | 1.7M | 18.86% |
| 2019-02-14 | Fund Management, LLC | 89000.0 | 5.59% |
| 2019-02-14 | Glass | 489K | 5.59% |
| 2019-02-14 | Absolute Return Strategies LP | 89000.0 | 5.59% |
| 2019-02-13 | Chardan Investments, LLC | 1.71M | 18.90% |
| 2019-02-13 | Jonas Grossman | 1.71M | 18.90% |
| 2018-12-21 | RTW Master Fund, Ltd. | 500.2K | 5.72% |
| 2018-12-21 | Roderick Wong | 600K | 6.86% |
| 2018-12-21 | RTW Investments, LP | 600K | 6.86% |
| 2018-12-20 | Fund Management, LLC | 800K | 9.14% |
| 2018-12-20 | Absolute Return Strategies LP | 800K | 9.14% |
| 2018-12-20 | Glass | 800K | 9.14% |
PHGE Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.87 | 69.81M | $130.54M | $4.96M | $1.44M | $127.02M |
| 2024-12-31 | $13.87 | 3.67M | $50.96M | $17.81M | $9.58M | $42.73M |
| 2023-12-31 | $53.20 | 2.7M | $143.72M | $14.91M | $15.09M | $143.91M |
| 2022-12-31 | $35.53 | 1.57M | $55.82M | $31.33M | $19.36M | $43.85M |
| 2021-12-31 | $304.00 | 1.37M | $416.16M | $62.1M | $20.02M | $374.08M |
| 2020-12-31 | $1212.20 | 1.21M | $1.47B | $36.48M | $5.9M | $1.44B |
| 2019-12-31 | $1840.15 | 1.19M | $2.19B | $72.41M | $1.23M | $2.12B |
| 2018-12-31 | $1833.50 | 1.05M | $1.93B | $8.6M | -$ | $1.92B |
| 2018-06-30 | $1833.50 | 1.04M | $1.9B | $6.99M | $40000 | $1.89B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.75 | 2.6M | $9.76M | $1.17M | -$ | $8.6M |
| 2025-12-31 | $1.87 | 69.81M | $130.54M | $4.96M | $1.44M | $127.02M |
| 2025-09-30 | $9.98 | 36.74M | $366.68M | $7.91M | $6.58M | $365.36M |
| 2025-06-30 | $8.55 | 36.74M | $314.14M | $14.05M | $9.38M | $309.47M |
| 2025-03-31 | $10.56 | 36.74M | $387.99M | $20.12M | $9.29M | $377.17M |
| 2024-12-31 | $13.87 | 3.67M | $50.96M | $17.81M | $9.58M | $42.73M |
| 2024-09-30 | $19.38 | 3.67M | $71.21M | $23.54M | $9.75M | $57.42M |
| 2024-06-30 | $64.79 | 3.67M | $238.05M | $32.71M | $9.9M | $215.23M |
| 2024-03-31 | $77.90 | 3.28M | $255.39M | $44.12M | $10.12M | $221.4M |
| 2023-12-31 | $53.20 | 2.42M | $128.74M | $14.91M | $15.09M | $128.93M |
| 2023-09-30 | $66.88 | 3.19M | $213.28M | $22.45M | $16.21M | $207.03M |
| 2023-06-30 | $68.40 | 2.71M | $185.58M | $29.71M | $17.6M | $173.47M |